Key result
Review of vasodilatory shock management highlights a lack of randomized trials to guide treatment.
Why the study?
Only few randomized studies exist to guide clinical management and hemodynamic stabilization in patients with vasodilatory shock who do not respond to the standard approach.
This review provides updates on the management of vasodilatory shock and a framework for future research.
Without RCTs, vasodilatory shock care remains empiric; leaves open rigorous trials to define best practices.
Vasodilatory shock is a critical manifestation of cardiovascular failure. There is uncontrolled vasodilation and vascular hyporesponsiveness to endogenous vasoconstrictors, causing the failure of physiologic vasoregulatory mechanisms. Unfortunately, only few randomized studies exist to guide clinical management and hemodynamic stabilization in patients who do not respond to the standard approach of managing vasodilatory shock. The present review offers the latest updates in management of this important clinical entity and a guidance framework for future research. HOW TO CITE THIS ARTICLE: Lahiry S, Thakur S, Chakraborty DS. Advances in Vasodilatory Shock: A Concise Review. Indian J Crit Care Med 2019;23(10):475-480.
No takes yet. Share an insight, caveat, or question.
Sayanta Thakur (2019) conducted a review in Vasodilatory shock. This review summarizes the latest updates in the clinical management and hemodynamic stabilization of vasodilatory shock, highlighting the lack of randomized studies to guide treatment.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: